Accord Healthcare US Reintroduces Hydrochlorothiazide Tablets, Expanding Access Across All Three Strengths
PR Newswire —
RALEIGH, N.C., April 1, 2026 /PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the re‑launch of Hydrochlorothiazide Tablets, USP in 12.5 mg, 25 mg, and 50 mg strengths....